Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis
about
Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trialsAspirin for primary prevention of cardiovascular diseaseA systematic review of aspirin in primary prevention: is it time for a new approach?Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.Cardiovascular Disease in Women: Clinical Perspectives.Diabetes and cardiovascular disease: from evidence to clinical practice - position statement 2014 of Brazilian Diabetes Society.Aspirin for primary prevention of cardiovascular events: meta-analysis of randomized controlled trials and subgroup analysis by sex and diabetes status.Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES studyStrategies for improving cardiovascular health in women with diabetes mellitus: a review of the evidence.Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Drug delivery and therapeutic impact of extended-release acetylsalicylic acid.Controversies surrounding percutaneous coronary intervention in the diabetic patient.Aspirin use is associated with lower indices of liver fibrosis among adults in the United States.Aspirin in the prevention of cardiovascular events in patients with diabetes.Japanese Clinical Practice Guideline for Diabetes 2016.
P2860
Q21132402-73C04133-8241-4DE5-B0B3-D1BE370CB925Q26774150-F5E3BDBA-AF25-4252-87F8-2B6B766402ECQ26864015-74A37BD2-D325-4F54-84B3-867A968FB807Q27687851-71DF67AB-50D1-44CF-B8AB-63D4C95CDAFDQ30743765-0B0E14D8-2016-4CE6-B384-465E68382505Q33647298-A20E6759-5213-4A8E-9896-3C9979871D3DQ34433987-85A57A4B-4E64-4E71-BACA-2F5ADFAAB377Q35022756-D7CA91FE-1738-4DE1-B1F9-F35F2FF596EDQ36950782-134D78B6-26A3-44DB-9CEB-3F9E258182BEQ37251490-460A1695-6218-4371-B08E-925489B29B89Q38584104-7B22422C-2C65-40B0-B0F5-08CD2CCE7218Q38720113-B41A3206-C42E-4920-8FF8-E8A25B1FDF77Q40124752-2E541BAD-581F-4F39-84B3-5DE66606419CQ40225996-F71421F8-2C4E-46A3-B1DE-666F16227F34Q55069710-7E24D640-AD71-4C40-A1BC-319CCA307AAE
P2860
Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effect of aspirin dose on mort ...... with diabetes: a meta-analysis
@ast
Effect of aspirin dose on mort ...... with diabetes: a meta-analysis
@en
type
label
Effect of aspirin dose on mort ...... with diabetes: a meta-analysis
@ast
Effect of aspirin dose on mort ...... with diabetes: a meta-analysis
@en
prefLabel
Effect of aspirin dose on mort ...... with diabetes: a meta-analysis
@ast
Effect of aspirin dose on mort ...... with diabetes: a meta-analysis
@en
P2860
P1476
Effect of aspirin dose on mort ...... with diabetes: a meta-analysis
@en
P2093
Laurie Mereu
Scot H Simpson
P2860
P2888
P304
P356
10.1007/S11606-011-1757-Y
P577
2011-06-07T00:00:00Z